Kadono Y. Editorial Comment to Comparison of disease-specific quality of life in prostate cancer patients treated with low-dose-rate brachytherapy: A randomized controlled trial of silodosin versus naftopidil. Int J Urol 2021 Sep 8. doi: 10.1111/iju.14690.
PMID: 34498287